The simplest way to get in touch with us is to use our contact form.
Gadget tips? Please use our contact form.
Would you like to join our editorial team? Or maybe you’re interested in contributing a guest post to Medgadget? Please use our contact form to let us know what you have in mind, and we will be in touch with you.
As though to follow up on our post from yesterday about how we perceive color, TED has released a new video of Beau Lotto demonstrating what visual illusions say about how our brains function.
All of this year’s Nobel Prizes in the sciences were very relevant to healthcare and biomedical research. Our readers were able to guess the Medicine and Chemistry winners, but no one named the Physicists.
And now, a drum roll…. Beth Cimini was the first person to correctly guess all three of the winners of The Nobel Prize in Physiology or Medicine 2009. Coincidentally, Beth is a student in Dr. Elizabeth H. Blackburn’s lab at UCSF, one of the winners of the Nobel Prize. Congratulations Beth, and we hope you can also relay our congratulations to Dr. Blackburn. David Staple, a Technology Specialist at the IP Law firm of Casimir Jones SC in Madison, Wisconsin was the only person to correctly guess the winners of The Nobel Prize in Chemistry 2009. Of note, David believes that Harry Noller, a major figure in ribosome research, was wrongfully omitted from the Nobel prize. Congratulations David, on your cunning and sharp guessing.
Both of today’s winners will receive an individually engraved Apple iPod Touch.
We’d like to thank everyone for playing and be sure to play Guess-A-Nobel again at around the same time next year. Link: Announcing The 2009 Guess-A-Nobel Contest…
Cheap DNA sequencing is a holy grail for geneticists and advocates of personalized medicine. IBM has embarked on its own search for a technology, capable of bringing down personalized genome sequencing to $1,000. The technique they’re currently pursuing involves running a DNA thread through a nanopore three nanometers wide. Inside would be an electrical sensor that can distinguish which of the four DNA bases is in proximity. If the DNA can be moved through the nanopore quickly enough with short pauses for base readings, the project researchers believe this approach will make genome sequencing common for clinical applications.
IBM Research is working to optimize a process for controlling the rate at which a DNA strand moves through a nano-scale aperture on a thin membrane during analysis for DNA sequencing. While scientists around the world have been working on using nanopore technology to read DNA, nobody has been able to figure out how to have complete control of a DNA strand as it travels through the nanopore. Slowing the speed is critical to being able to read the DNA strand. IBM scientists believe they have a unique approach that could tackle this challenge.
To control the speed at which the DNA flows through the microprocessor nanopore, IBM researchers have developed a device consisting of a multilayer metal/dielectric nano-structure that contains the nanopore. Voltage biases between the electrically addressable metal layers will modulate the electric field inside the nanopore. This device utilizes the interaction of discrete charges along the backbone of a DNA molecule with the modulated electric field to trap DNA in the nanopore. By cyclically turning on and off these gate voltages, scientists showed theoretically and computationally, and expect to be able prove experimentally, the plausibility of moving DNA through the nanopore at a rate of one nucleotide per cycle – a rate that IBM scientists believe would make DNA readable.
Image: A membrane containing the nanopore, funtionalized with metal contacts (orange) separated by dielectric materials (lime), devides a reservoir into a top part containing an ionic solution with a high concentration of single stranded DNA, and a bottom part, where the DNA will be translocated to. The DNA on the top reservoir is induced to go to the bottom reservoir by the action of a biasing voltage. In the absence of anything else, the DNA would translocate through the pore at a speed of several million bases per second. To control the passage of DNA trhough the nano-hole, voltages of appropriate polarity (not shown) are applied to the metal contacts inside the pore, which create an internal electric field that trap the DNA. By alternating the trapping voltages applied to the metal contacts, the DNA can be made ratchet from the top to the bottom reservoirs in a controlled way.
Even though we intuitively think that a particular color looks the same to different people, researchers from The University of Chicago and Vanderbilt University have uncovered that the brain plays a critical role in color perception. The brain actually assigns colors to objects and with a bit of tinkering one can fool the brain to assign the wrong color to an object being viewed.
“An aspect of human vision that we normally don’t appreciate is that different features of an object, including color and shape, can be represented in different parts of the brain,” said Shevell, the Eliakim Hastings Moore Distinguished Service Professor in Psychology and Ophthalmology & Visual Science.
If a person sees a basketball coming, it is perceived as having a particular color, shape and velocity. “The knitting together, or what can be called ‘neural gluing,’ of all those different features so we see a unified object is a complex function done by the brain. Our research focused on how the brain does that,” Shevell explained.
To study how the brain represents the color of objects, the researchers used a technique called binocular rivalry. The technique presents a different image to each eye and thus pits signals from the right eye against signals from the left.
“The brain has difficulty integrating the two eyes’ incompatible signals. When the signals from the two eyes are different enough, the brain resolves the conflicting information by suppressing the information from one of the eyes,” Shevell said. “We exploited this feature of the brain with a method that caused the shape from one eye to be suppressed but not its color.”
The researchers first showed subjects vertically oriented green stripes in the left eye and a horizontally oriented set of red stripes in the right eye. “The brain cannot fuse them in a way that makes sense. So the brain sees only horizontal or vertical,” Shevell said. For their study, the researchers developed a new form of the technique that allowed the horizontal pattern to be suppressed without eliminating its red color, which continued on to the brain.
At this point, the brain has a musical chairs problem. Both the red and green colors reach consciousness but with only the one vertical pattern–one object but two colors. The surprising result was that the “disembodied red, which originated from the unseen horizontal pattern in one eye, glued itself to parts of the consciously seen vertical pattern from the other eye. That proves the idea of neural binding or neural gluing, where the color is connected to the object in an active neural process,” Shevell said.
Scientists at Philips have developed a new fully digital silicon photomultipliers (SiMP’s) that may replace detectors within PET scanners as well as open up possibilities for other ultra-sensitive detectors for DNA sequencing and protein/DNA microarrays.
By integrating low-power CMOS electronics into the silicon photomultiplier chip, the team at Philips has developed a digital silicon photomultiplier in which each photon detection is converted directly into an ultra high speed digital pulse that can be directly counted by on-chip counter circuitry. In contrast to conventional silicon photomultipliers, the Philips digital silicon photomultiplier is therefore an all-digital (digital-in/digital-out) device. As a result, it produces faster and more accurate photon counts with extremely well defined timing of the first photon detection, both of which are important factors in applications such as medical imaging scanners and high-energy nuclear particle detectors.
The PET system detects pairs of gamma rays (high energy electromagnetic radiation) originating from a radioactive tracer, a small amount of which is injected into the patient prior to the scan. To image metabolic activity, PET typically uses a radioactive derivative of glucose called fluorodeoxyglucose (FDG). This compound mimics the behavior of glucose in the body and can be detected by the PET system.
For so-called ‘time-of-flight’ PET scanners, accurately determining the time at which the first photon arrives at the detector is extremely important. Philips’ digital silicon photomultiplier prototypes achieve a timing accuracy for the detection of the first photon of around 190 ps (full-width, half-maximum using a standard scintillator crystal (LYSO) at 511 keV for two detectors in coincidence).
Conventional silicon photomultipliers (SiPMs) consist of a two-dimensional array of avalanche photodiodes (APDs) each of which is connected in series with its own polysilicon ‘quenching’ resistor. All of these diode/resistor ‘microcells’ are then connected in parallel and the entire microcell array is reverse-biased to a voltage above the diodes’ normal breakdown voltage – typically in the range 30V to 70V. Operating in this so-called ‘Geiger mode’, the diodes are ultra-sensitive to single electron-hole pairs that result in individual diodes experiencing avalanche breakdown. These electron-hole pairs can be generated either by the absorption of a photon (the desired signal), or by thermal energy or electron tunneling (unwanted background noise). The unwanted background noise produced by thermally generated electron-hole pairs and/or electron tunneling, together with false counts due to defective microcells, are collectively referred to as the SiPM’s ‘dark count’.
To eliminate a conventional SiPM’s need for an external digitizing ASIC, the digital silicon photomultiplier developed by Philips equips each individual avalanche photodiode with its own 1-bit on-chip ADC (Analog to Digital Converter) in the form of a CMOS inverter. Each microcell that experiences avalanche breakdown therefore produces its own digital output that is captured, along with the digital outputs from all other triggered microcells, by an on-chip counter. The Philips digital SiPM therefore converts digital events (photon detections) directly into a digital photon count. As a result, it is capable of achieving significantly better resolution than conventional SiPMs.
To overcome the ‘dark count’ problem associated with conventional SiPMs, each microcell in the Philips digital SiPM is also equipped with an addressable static memory cell that can be used to disable or enable the microcell. Microcells that show high dark count levels can therefore be prevented from contributing false counts to the SiPM’s output. This facility allows the Philips’ digital SiPM to achieve better signal-to-noise ratios than conventional devices. Because defective microcells in the array can be disabled, it also helps to improve production yield.
Nanowerk is spotlighting research by Argonne National Laboratory scientists to develop bioconjugated nanoparticles that seek out brain tumor cells while avoiding attack on healthy tissue. Although various nanoparticles tend to passively gather in larger numbers in tumor cells due to the so-called “permeability and retention effect”, the differentiation is not specific enough when dealing with particularly fragile brain tissue. Nanowerk explains:
The delivery platform developed by Rozhkova [Elena Rozhkova from Argonne's NanoBio Interfaces group] and her colleagues uses 5 nm titanium dioxide nanoparticles that are covalently conjugated with an antibody that specifically targets certain tumors, including GBM. A naturally occurring metabolite of dopamin, DOPAC, is used as a linker molecule to tether the antibody to the nanoparticles.
The whole thing works like this: the titanium dioxide/antibody nanobiocomposite binds exclusively to GBM cells. The hybrid semiconductor particles absorb energy from light, which is then transferred to molecular oxygen, producing cytotoxic reactive oxygen species (ROS). ROS damages the cell membrane and induces programmed death of the cancer cell.
Designers Fredrik Hyltén-Cavallius and Jacob von Matern teamed up with the NASA Johnson Space Center to conceptualize a portable X-ray machine for field applications. Small enough to discreetly find itself on a football or rugby field sidelines, the device would use a standard laptop for image processing and visualization. More from Yanko Design… Link: Cavallius Design…
MedPageToday has published an interesting article that looks at the evidence of whether surgical masks, as well as tight seal respirators, such as N95, provide any protection to healthcare workers or patients. So what’s the article’s findings? The evidence that masks provide any meaningful respiratory shield is indeed quite slim, even for the operating room environment. Hence the conclusion:
“Masks and respirators should be considered the ‘last line of defense’ in a hierarchy of infection control measures.”